Answers are grounded in this paper and cite their sources.
Inflammation plays an important role in proliferation, migration, and invasion of tumor cells; therefore, many research has been done to investigate inflammation parameters including systemic immune-inflammatory index (SII). Dexamethasone, a strong anti-inflammatory, is still widely used as the main treatment in vasogenic edema. High-dose administration (16 mg/day) is recommended in patients with brain tumors with increased intracranial pressure. We performed this retrospective study to determine SII profile, dexamethasone use, and the effect of high-dose dexamethasone on SII in patients with brain tumors.
No takes yet. Share an insight, caveat, or question.
Simanungkalit et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: